125 related articles for article (PubMed ID: 12002648)
41. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
Chen I; Kaufisi P; Erdem G
J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
[TBL] [Abstract][Full Text] [Related]
42. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
43. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
44. Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization.
Akata F; Oztürk D; Tansel O; Tatman-Otkun M; Otkun M; Fitoussi F; Bingen E; Tugrul M
Int J Antimicrob Agents; 2002 Dec; 20(6):461-3. PubMed ID: 12458142
[TBL] [Abstract][Full Text] [Related]
45. Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci.
Jasir A; Schalén C
Adv Exp Med Biol; 1997; 418():443-5. PubMed ID: 9331689
[No Abstract] [Full Text] [Related]
46. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
47. Molecular characterization of Group A streptococcal isolates causing scarlet fever and pharyngitis among young children: a retrospective study from a northern Taiwan medical center.
Wu PC; Lo WT; Chen SJ; Wang CC
J Microbiol Immunol Infect; 2014 Aug; 47(4):304-10. PubMed ID: 23639381
[TBL] [Abstract][Full Text] [Related]
48. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
49. Erythromycin resistance of Streptococcus pyogenes in Madrid.
Orden B; Perez-Trallero E; Montes M; Martínez R
Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
[TBL] [Abstract][Full Text] [Related]
50. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
Kaya EG; Yücel M; Karakoç AE
Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
[TBL] [Abstract][Full Text] [Related]
51. Presence of plasmid pA15 correlates with prevalence of constitutive MLS(B) resistance in group A streptococcal isolates at a university hospital in southern Taiwan.
Liu YF; Wang CH; Janapatla RP; Fu HM; Wu HM; Wu JJ
J Antimicrob Chemother; 2007 Jun; 59(6):1167-70. PubMed ID: 17460027
[TBL] [Abstract][Full Text] [Related]
52. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.
Figueira-Coelho J; Ramirez M; Salgado MJ; Melo-Cristino J
Microb Drug Resist; 2004; 10(1):31-6. PubMed ID: 15140391
[TBL] [Abstract][Full Text] [Related]
53. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
[TBL] [Abstract][Full Text] [Related]
54. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
55. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
56. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.
Reinert RR; Lütticken R; Sutcliffe JA; Tait-Kamradt A; Cil MY; Schorn HM; Bryskier A; Al-Lahham A
Antimicrob Agents Chemother; 2004 Apr; 48(4):1369-73. PubMed ID: 15047546
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea.
Kim S; Lee NY
J Antimicrob Chemother; 2004 Aug; 54(2):447-50. PubMed ID: 15269193
[TBL] [Abstract][Full Text] [Related]
58. [Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
De Rosa R; Avolio M; Stano P; Modolo ML; Camporese A
Infez Med; 2009 Jun; 17(2):82-7. PubMed ID: 19602920
[TBL] [Abstract][Full Text] [Related]
59. Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene.
Spinaci C; Magi G; Zampaloni C; Vitali LA; Paoletti C; Catania MR; Prenna M; Ferrante L; Ripa S; Varaldo PE; Facinelli B
J Clin Microbiol; 2004 Feb; 42(2):639-44. PubMed ID: 14766830
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.
De Azavedo JC; Yeung RH; Bast DJ; Duncan CL; Borgia SB; Low DE
Antimicrob Agents Chemother; 1999 Sep; 43(9):2144-7. PubMed ID: 10471555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
